Values as of: 2024-06-15
COMMON STOCK | Agricultural Inputs |
Last Closing
USD 12.59Change
0.00 (0.00)%Market Cap
USD 2.43BVolume
3.76KAnalyst Target
N/AVerdict
Verdict
Currency: EUR
Country : Germany
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| 2X0:F | Corteva Inc |
N/A |
USD 33.83B |
| N7T:F | Nutrien Ltd |
N/A |
USD 23.55B |
| C4F:F | CF Industries Holdings Inc |
N/A |
USD 12.71B |
| 02M:F | The Mosaic Company |
N/A |
USD 8.35B |
| IU2:F | Yara International ASA |
N/A |
USD 6.72B |
| IU20:F | YARA INTL ASA ADR NK170 |
N/A |
USD 6.71B |
| FMQ:F | FMC Corporation |
N/A |
USD 6.64B |
| SCQA:F | The Scotts Miracle-Gro Company |
N/A |
USD 3.60B |
| SDF1:F | K+S Aktiengesellschaft |
N/A |
USD 2.26B |
| KWS:F | KWS SAAT SE & Co. KGaA |
N/A |
USD 1.97B |
N/A
| Market Performance vs. Industry/Classification (Agricultural Inputs) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -11.59% | 47% | F | 29% | F | ||
| Dividend Return | 4.92% | 73% | C | 65% | D | ||
| Total Return | -6.67% | 50% | F | 32% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -19.37% | 47% | F | 31% | F | ||
| Dividend Return | 4.48% | 73% | C | 47% | F | ||
| Total Return | -14.89% | 53% | F | 31% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | -20.34% | 38% | F | 29% | F | ||
| Dividend Return | 13.22% | 64% | D | 49% | F | ||
| Total Return | -7.12% | 38% | F | 27% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 30.94% | 94% | A | 92% | A | ||
| Dividend Return | 32.98% | 89% | A- | 87% | B+ | ||
| Total Return | 2.04% | 75% | C | 57% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 76.36% | 9% | A- | 12% | F | ||
| Risk Adjusted Return | 43.18% | 80% | B- | 68% | D+ | ||
| Market Capitalization | 2.43B | 77% | C+ | 70% | C- | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
This stock has shown below median revenue growth in the previous 5 years compared to its sector
